Gastric Bypass Often a strong option for reflux, diabetes, revision surgery, or selected higher-risk situations
N Engl J Med 375:311322 Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
Data extraction Two designated authors (AM and SS) meticulously extracted pertinent data from the included studies, including authorship details, publication timeline, samples of the study, mean demographic parameters (e.g., age, sex, baseline weight, and baseline BMI), type of bariatric surgery, prevalent background diseases, type of the GLP-1RAs therapy, the time of the initiation of the medical treatment, laboratory indices, amount of weight-change, and a comprehensive array of outcome measures, such as nausea, vomiting, diarrhea, and serious adverse events
Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity
At a 24% federal rate, using your HSA to cover compounded semaglutide ($189/month = $2,268/year ($189/mo)) saves approximately $429 in federal taxes annually
Here is the dose conversion between Mounjaro and Wegovy, showing which dose youll likely start on based on the dose you are currently taking: View our guide on Switching from Mounjaro to Wegovy as well as Switching from Wegovy to Mounjaro for more information